What's the most recent regulatory action in Prevention of premature ovulation?

Most recent: Cetrotide — FDA approved.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/prevention-of-premature-ovulation.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Prevention of premature ovulation — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevention of premature ovulation (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Prevention of premature ovulation, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Cetrotide	CETRORELIX	Merck KGaA	Gonadotropin Releasing Hormone Receptor Antagonist	Gonadotropin-releasing hormone receptor	2000-01-01
Synarel	NAFARELIN	Pfizer	Gonadotropin Releasing Hormone Receptor Agonist	Gonadotropin-releasing hormone receptor	1990-01-01
Receptal	BUSERELIN	Sanofi K.K.	buserelin	Gonadotropin-releasing hormone receptor
Cetrotide	Cetrotide	Wolfson Medical Center		Gonadotropin-releasing hormone receptor, Lutropin-choriogonadotropic hormone receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

2026-04-29 — Cetrotide · FDA · approved · US

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Merck KGaA · 1 drug in Prevention of premature ovulation
Pfizer · 1 drug in Prevention of premature ovulation
Sanofi K.K. · 1 drug in Prevention of premature ovulation
Wolfson Medical Center · 1 drug in Prevention of premature ovulation

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Prevention of premature ovulation:

Cite this brief

Drug Landscape (2026). Prevention of premature ovulation — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/prevention-of-premature-ovulation. Accessed 2026-06-10.

Prevention of premature ovulation full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing